Healthy volunteers. Intended indication is Clinical High Risk for Psychosis (CHR-P). research hub

A phase 1 open-label study to assess the safety and PK of novel CBD soft-gel capsule

This study is testing a new CBD capsule to see how well it's absorbed and if it's safe. It compares two doses of the new CBD with an existing CBD medicine called Epidyolex in healthy volunteers. The goal is to find a better CBD option.